Skip to main content
FinSpry Logo
FinSpry
TAK logo
TAK
(NYSE)
Takeda Pharmaceutical Company Limited
$16.58-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Takeda Pharmaceutical Company (TAK) Stock Price & Financial Analysis

Takeda Pharmaceutical Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.46 - $16.67
52-Week High$18.90
52-Week Low$12.99
Open$16.54
Volume2.34M
Average Volume (3M)3.08M
Market Cap53.11B
Shares Outstanding3.20B
P/E Ratio (TTM)73.74
Forward P/E133.06
Price to Sales (P/S)1.89
Price to Book (P/B)1.11
EV/EBITDA9.66
Revenue (TTM)28.21B
Net Income (TTM)721.95M
Free Cash Flow (TTM)5.91B
EPS (TTM)$0.23
Profit Margin2.56%
Operating Margin14.98%
Return on Equity (ROE)1.50%
Debt to Equity0.58
50-Day MA$17.61
200-Day MA$15.85
52-Week Change15.29%
Annual Dividend$0.62
Dividend Yield3.75%
Payout Ratio200.00%
Last Dividend Ex-DateMar 31, 2027

Frequently Asked Questions About Takeda Pharmaceutical Company

What is the current stock price for TAK?

As of the latest trading session, TAK stock trades at $16.58. The 52-week range is $12.99–$18.90, with a day range of $16.46–$16.66.

What is the P/E ratio for TAK?

Takeda Pharmaceutical Company's trailing P/E ratio is 73.7, meaning investors pay $73.7 for every $1 of annual earnings. The forward P/E is 133.1, reflecting analyst expectations for future earnings. Takeda Pharmaceutical Company operates in the Healthcare sector.

Does TAK pay dividends?

Yes, Takeda Pharmaceutical Company pays a 3.75% annual dividend yield ($0.62 per share). The payout ratio is 200.0%. The last ex-dividend date was 2027-03-31.

What do analysts recommend for TAK?

Analyst ratings and recommendations for TAK are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of TAK?

Takeda Pharmaceutical Company's market capitalization is $53.14B, classifying it as a large-cap company. Takeda Pharmaceutical Company operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.